SYPR News and Press, Sypris Solutions Inc. From 05/18/22

The following slide deck was published by Sypris Solutions, Inc. in conjunction with their 2022 Q1 earnings call. For further details see: Sypris Solutions, Inc. 2022 Q1 - Results - Earnings Call Presentation

Sypris Solutions press release (NASDAQ:SYPR): Q1 GAAP EPS of $0.01. Revenue of $26.16M (+30.9% Y/Y). The Company reaffirmed its full-year outlook for 2022, with revenue expected to increase 25%-30% year-over-year. Additionally, the Company continues to forecast a 200-250 basis point gross mar...

Louisville, Ky., May 13, 2022 (GLOBE NEWSWIRE) -- Sypris Solutions, Inc. (NASDAQ/GM: SYPR) (“Sypris” or the “Company”) today announced that it will host a conference call on Wednesday, May 18, 2022, at 9:00 a.m. ET to discuss financial results and operations. To ...

To Supply Drivetrain Components for Commercial Vehicles Sypris Technologies, Inc., a subsidiary of Sypris Solutions, Inc. (Nasdaq/GM: SYPR), announced today that it has entered into a multi-year contract extension to provide drivetrain components for use in the production of...

Sypris Solutions, Inc. (SYPR) Q4 2021 Earnings Conference Call March 17, 2022 9:00 AM ET Company Participants Jeffrey Gill - President and Chief Executive Officer Anthony Allen - Chief Financial Officer Conference Call Participants Presentation Operator Good day, and welcome to the Sypris Sol...

The following slide deck was published by Sypris Solutions, Inc. in conjunction with their 2021 Q4 earnings call. For further details see: Sypris Solutions, Inc. 2021 Q4 - Results - Earnings Call Presentation

Sypris Solutions press release (NASDAQ:SYPR): Q4 GAAP EPS of -$0.02. Revenue of $25.8M (+25.2% Y/Y). For further details see: Sypris Solutions GAAP EPS of -$0.02, revenue of $25.8M

Summer Infant (SUMR) +29% on Q4 results. Imperial Petroleum (IMPP) +19%. Mullen Automotive (MULN) +19% featured by Yahoo Finance live. Indonesia Energy (INDO) +18%. F-star Therapeutics (FSTX) +16%. Enservco (ENSV) +16%. Aquestive Therapeutics (AQST) +16% receives FDA fast track...

Sypris Solutions press release (NASDAQ:SYPR): Q4 GAAP EPS of $0.02. Revenue of $25.8M (+25.2% Y/Y). CEO comment: “We expect our backlog and markets to support continued revenue and earnings growth during 2022. We have updated our outlook accordingly, with revenue forecast to increase 2...

EPS UP 133%; BACKLOG UP 57%; 2022 OUTLOOK RAISED Sypris Solutions, Inc. (Nasdaq/GM: SYPR) today reported financial results for its fourth quarter and full-year ended December 31, 2021. HIGHLIGHTS ────────%...